ArticleBMC neurology2026
Nomogram prediction model for prognosis of patients with amyotrophic lateral sclerosis.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesTo analyze the factors affecting prognosis of patients with sporadic amyotrophic lateral sclerosis (ALS), to establish a nomogram predictive model.
methodsA total of 236 patients with sporadic ALS hospitalized in the Department of Neurology of the First Medical Center, Chinese PLA General Hospital, from March 2011 to November 2021 were enrolled in the study. Basic information and clinical and laboratory data of patients were collected, including sex, age at onset, body mass index, disease duration, diagnostic grade, and serum levels of creatine kinase (CK), creatinine (Cr), uric acid (UA), and ferritin. Kaplan-Meier univariate and multivariate Cox proportional hazard regression models were used to analyze the prognostic factors, and a nomogram predictive model was established.
resultsUnivariate analysis showed that ferritin, CK, Cr, age at onset, disease duration, and body mass index (BMI) were all correlated with prognosis of ALS. Multivariate analysis showed that ferritin, Cr, disease duration, age at onset, and BMI were the strongest predictors. ROC curve and correction curve analyses verified the accuracy of the nomogram prediction model.
conclusionsFerritin, Cr, disease duration, age at onset, and BMI are independent predictors of survival in patients with ALS. Based on these clinical and biological prognostic factors, we established a quantitative model for predicting survival probability, and may assist in the prognostic evaluation of ALS, pending further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.